Why the study?
Fontan-associated liver disease is a major long-term complication after the Fontan procedure that can progress to cirrhosis and hepatocellular carcinoma, yet strategies to identify high-risk individuals and provide prognostic information remain limited.
This consensus statement compiles multidisciplinary expertise from congenital heart disease specialists and hepatologists to guide early diagnosis, structured follow-up, and management of Fontan-associated liver disease.
Answers are grounded in this paper and cite their sources.
Supports multidisciplinary surveillance in Fontan patients; leaves open validation of protocols and HCC screening via prospective registries.
The Fontan procedure has been transformative for patients with univentricular physiology. By using a single ventricle as the systemic pump and relying on passive venous return to drive pulmonary circulation, Fontan circulation alleviates cyanosis and heart failure, allowing children to engage in normal activities during school and adolescence. Nevertheless, Fontan circulation is characterized by chronically elevated systemic venous pressure, which leads to systemic venous congestion and long‐term multiorgan effects. Fontan‐associated liver disease (FALD) is now recognized as a major long‐term complication. Approximately 50% of patients develop hepatic abnormalities within 10–20 years after surgery, and some progress to cirrhosis and hepatocellular carcinoma (HCC). Despite this risk, strategies to identify individuals at high risk for early HCC and to provide better prognostic information remain limited. This article compiles knowledge from congenital heart disease specialists and hepatologists on FALD, including areas where evidence is limited. By facilitating early diagnosis, structured follow‐up, and multidisciplinary management of FALD, this initiative aims to improve outcomes, build a nationwide clinical experience, and ultimately support the development of formal, evidence‐based guidelines for FALD management.
No takes yet. Share an insight, caveat, or question.
Kanto et al. (2026) conducted a review in Fontan-associated liver disease (FALD). Fontan procedure was evaluated on Hepatic abnormalities (Fontan-associated liver disease). Fontan circulation leads to hepatic abnormalities in approximately 50% of patients within 10-20 years post-surgery, prompting multidisciplinary consensus statements for FALD management.
Synapse has enriched 10 related papers. Consider them for comparative context: